CTRI/2023/03/050684已完成4 期
Dermatological safety evaluation of test products by Primary Irritation Patch Test within 24 hours of apply on healthy human all skin types.
KK organic0 个研究点目标入组 24 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Voluntary men and women ration of 1:1 between 18 and 65 years.
- •2.Having healthy skin on test area as assessed by dermatological examination.
- •3.For whom the investigator considers that the compliance will be correct.
- •4.Subjects with normal, dry, oily and combination skin
排除标准
- •1.Pregnant/nursing mothers.
- •2.Scars, excessive terminal hair, or tattoo on the studied area.
- •3.Dermatological infection/pathology on level of studied area.
- •4.Hypersensitivity, allergy antecedent (to any cosmetic product, raw material)
- •5.Any clinically significant systemic or cutaneous disease, which may interfere with study treatment or
- •procedures.
研究者
相似试验
已完成
不适用
Safety evaluation of test products within 24 hours on skin.CTRI/2022/01/039071Vasu Research Centre24
已完成
4 期
Safety evaluation of test products by PIPTCTRI/2023/03/050887Dabur India Limited24
已完成
4 期
Safety evaluation of test products by PIPT on all healthy human with all skin typesCTRI/2023/03/050690Emami Ltd24
已完成
4 期
To evaluate the safety of Primary Irritation Patch Test test product in healthy volunteersCTRI/2022/12/048219Vasu Health Care24
已完成
4 期
Safety evaluation of test products on healthy skin typeCTRI/2023/03/050796Dabur India Limited24